These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 11761988

  • 21. Hepatitis B virus in hepatocarcinogenesis.
    Feitelson MA.
    J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
    [Abstract] [Full Text] [Related]

  • 22. [Hepatitis B and primary cancer of the liver: recent data on the role of B virus in oncogenesis].
    Buendia MA.
    Pathol Biol (Paris); 1991 Feb; 39(2):157-60. PubMed ID: 1850121
    [Abstract] [Full Text] [Related]

  • 23. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study.
    Jayshree RS, Sridhar H, Devi GM.
    Cancer; 2003 Feb 25; 99(1):63-7. PubMed ID: 12589648
    [Abstract] [Full Text] [Related]

  • 24. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K.
    Nihon Rinsho; 1999 Jan 25; 57(1):213-9. PubMed ID: 10036965
    [Abstract] [Full Text] [Related]

  • 25. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S, Aizawa R, Abe H, Suto S, Miyakawa Y, Aizawa Y.
    Intern Med; 2003 May 25; 42(5):389-93. PubMed ID: 12793707
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 30. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.
    Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, Chan AO, Lai CL.
    Hepatology; 2003 Mar 15; 37(3):562-7. PubMed ID: 12601354
    [Abstract] [Full Text] [Related]

  • 31. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 15; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 32. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
    Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y, Shao RX, Dharel N, Tanaka Y, Ohta M, Tateishi R, Shiina S, Tatsukawa M, Fukai K, Imazeki F, Yokosuka O, Shiratori Y, Omata M.
    J Hepatol; 2006 Dec 15; 45(6):805-12. PubMed ID: 17050029
    [Abstract] [Full Text] [Related]

  • 33. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 15; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 34. Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?
    Röckelein G, Hecken-Emmel M.
    Hepatogastroenterology; 1988 Aug 15; 35(4):151-7. PubMed ID: 2846418
    [Abstract] [Full Text] [Related]

  • 35. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.
    Omer RE, Kuijsten A, Kadaru AM, Kok FJ, Idris MO, El Khidir IM, van 't Veer P.
    Nutr Cancer; 2004 Aug 15; 48(1):15-21. PubMed ID: 15203373
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 15; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 38. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS.
    J Infect Dis; 2006 May 01; 193(9):1258-65. PubMed ID: 16586363
    [Abstract] [Full Text] [Related]

  • 39. [Hepatitis DNA viruses and their correlation to hepatocellular cancer].
    Roggendorf M.
    Internist (Berl); 1985 Oct 01; 26(10):621-7. PubMed ID: 3000972
    [No Abstract] [Full Text] [Related]

  • 40. Epidemiology of hepatocellular carcinoma.
    Rustgi VK.
    Gastroenterol Clin North Am; 1987 Dec 01; 16(4):545-51. PubMed ID: 2831148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.